Page last updated: 2024-11-12

6-kestose

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

6-kestotriose : A trisaccharide that consists of sucrose having an additional fructosyl residue attached to the fructose residue via a beta-(2->6)-linkage. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID9914062
CHEBI ID64833
MeSH IDM0198571

Synonyms (21)

Synonym
6-kestotriose
6-KESTOSE ,
kestose, 6-
AAE9A8CC-2223-4E2E-84C7-100A261F8834
562-68-5
beta-d-fructofuranosyl-(2->6)-beta-d-fructofuranosyl alpha-d-glucopyranoside
(fruf)2 (glc)1
g7azf7cgy8 ,
einecs 209-232-9
unii-g7azf7cgy8
o-beta-d-fructofuranosyl-(2-6)-beta-d-fructofuranosyl-(2-1)-alpha-d-glucopyranoside
o-beta-d-fructofuranosyl-(2.6)-beta-d-fructofuranosyl-alpha-d-glucopyranoside
CHEBI:64833
glucopyranoside, o-.beta.-d-fructofuranosyl-(2->6)-.beta.-d-fructofuranosyl
.alpha.-d-glucopyranoside, o-.beta.-d-fructofuranosyl-(2->6)-.beta.-d-fructofuranosyl
glucopyranoside, o-.beta.-d-fructofuranosyl-(2->6)-.beta.-d-fructofuranosyl, .alpha.-d-
kestose
wurcs=2.0/2,3,2/[a2122h-1a_1-5][ha122h-2b_2-5]/1-2-2/a1-b2_b6-c2
Q27133478
DTXSID501318661
(2r,3r,4s,5s,6r)-2-(((2s,3s,4s,5r)-5-((((2r,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)tetrahydrofuran-2-yl)oxy)methyl)-3,4-dihydroxy-2-(hydroxymethyl)tetrahydrofuran-2-yl)oxy)-6-(hydroxymethyl)tetrahydro-2h-pyran-3,4,5-triol
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
trisaccharide
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
fructan biosynthesis09
fructan biosynthesis110
Fructan biosynthesis06

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (7.69)18.2507
2000's4 (30.77)29.6817
2010's8 (61.54)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.67

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.67 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index5.08 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.67)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (7.69%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (92.31%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]